Table 4. Comparison between FP and TP groups.
| Parameter | FP (n=15) | TP (n=12) | P value |
|---|---|---|---|
| BI (med) | 720.00 | 850.00 | 0.23 |
| N/L (med) | 3.39 | 2.97 | 0.44 |
| CEA (ng/mL, med) | 6.40 | 3.90 | 0.58 |
| T-CD (mm, med) | 39.00 | 32.80 | 0.60 |
| T-MD (mm, med) | 30.00 | 27.50 | 0.46 |
| T-SUVmax (med) | 17.14 | 17.04 | 0.25 |
| T-TLG (med) | 76.87 | 41.47 | 0.47 |
| HAU (n) | 4.00 | 10.00 | <0.01 |
FP, false-positive; TP, true-positive; BI, Brinkman index; N/L, neutrophil/lymphocyte ratio, CEA, carcinoembryonic antigen; T-CD, tumor consolidation dimension; T-MD, tumor dimension in the mediastinal window setting; T-SUVmax, tumor maximum of standardized uptake value; T-TLG, tumor total lesion glycolysis; HAU, hilar asymmetric uptake.